Abbott to evaluate TranXenoGen technology

ABT will evaluate the use of avian transgenic technology from TranXenoGen (LSE:TXN) to produce an undisclosed ABT monoclonal antibody in the egg albumin fraction of transgenic chicken eggs. ...